Home/Filings/4/0001567619-18-003109
4//SEC Filing

Templeman Blaine 4

Accession 0001567619-18-003109

CIK 0001435049other

Filed

Sep 24, 8:00 PM ET

Accepted

Sep 25, 8:10 PM ET

Size

5.2 KB

Accession

0001567619-18-003109

Insider Transaction Report

Form 4
Period: 2018-09-24
Templeman Blaine
Executive VP, General Counsel
Transactions
  • Sale

    Common Stock

    2018-09-24$5.81/sh10,262$59,613131,119 total
Footnotes (2)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2018.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.65 to $6.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Documents

1 file

Issuer

ADURO BIOTECH, INC.

CIK 0001435049

Entity typeother

Related Parties

1
  • filerCIK 0001653641

Filing Metadata

Form type
4
Filed
Sep 24, 8:00 PM ET
Accepted
Sep 25, 8:10 PM ET
Size
5.2 KB